Recurrent Melanoma Completed Phase 2 Trials for Interferon alfa-2b (DB00105)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00026143Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant MelanomaTreatment